Abstract
OBJECTIVE: Use our advanced, physiologically inspired cardiac CT perfusion (CCTP) software to distinguish ischemia due to obstructive disease vs. microvascular disease (MVD). BACKGROUND: Previously validated advanced CCTP methods were used. We interpreted results to identify flow-limiting stenosis [i.e., obstructive-lesion & low myocardial blood flow (MBF)] vs. microvascular disease (i.e., no-obstructive-lesion & low-MBF). METHODS: We retrospectively evaluated 104 patients with suspected CAD, including 18 with diabetes, who underwent CCTA + CCTP. Whole heart and territorial MBF was assessed using our automated pipeline for CCTP analysis that included beam hardening correction; temporal scan registration; automated segmentation; fast, accurate, robust MBF estimation; and visualization. Stenosis severity was scored using the CCTA coronary-artery-disease-reporting-and-data-system (CAD-RADS), with obstructive stenosis deemed as CAD-RADS ≥ 3. RESULTS: We established a threshold MBF (MBF = 200-mL/min-100 g) for normal perfusion. In patients with CAD-RADS ≥ 3 (obstructive disease), 28/37(76%) patients showed ischemia in the corresponding territory. On a per-vessel basis (n = 256), MBF showed a significant difference between territories with and without obstructive stenosis (165 ± 61 mL/min-100 g vs. 274 ± 62 mL/min-100 g, p < 0.05). A significant negative rank correlation (ρ = -0.53, p < 0.05) between territory MBF and CAD-RADS was seen. Two patients with obstructive disease had normal perfusion, suggesting collaterals and/or hemodynamically insignificant stenosis. Among diabetics, 10 of 18 (56%) demonstrated diffuse ischemia consistent with MVD. Among non-diabetics, only 6% had MVD. Sex-specific prevalence of MVD was 21%/24% (M/F). CONCLUSION: CCTA in conjunction with a new automated quantitative CCTP approach can determine the distinction of ischemia due to obstructive lesions vs. MVD.